Primary prevention of diabetes mellitus type two and cardiovascular diseases using a cognitive behaviour programme aimed at lifestyle changes in people with abdominal obesity

ISRCTN ISRCTN59358434
DOI https://doi.org/10.1186/ISRCTN59358434
Secondary identifying numbers N/A
Submission date
26/02/2007
Registration date
26/02/2007
Last edited
13/02/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J Lakerveld
Scientific

VU University Medical Centre
EMGO-Institute
Afd. Huisartsgeneeskunde
Amsterdam
1081 BT
Netherlands

Phone +31 20 444 8167
Email j.lakerveld@vumc.nl

Study information

Study designRandomised, active controlled, parallel group, multicentre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titlePrimary prevention of diabetes mellitus type two and cardiovascular diseases using a cognitive behaviour programme aimed at lifestyle changes in people with abdominal obesity
Study objectivesIt is hypothesised that a cognitive behavioural program that in particular is focused on motivation and self-management in persons at high risk for Cardiovascular Disease (CVD) and/or Diabetes Mellitus type two (DM2) will change their behaviour, which reduces the risk on developing DM2 and the risk on CVD.
Ethics approval(s)VU University Medical Center on 06/2007 (Ref: 2007/107)
Health condition(s) or problem(s) studiedDiabetes Mellitus type two (DM2), cognitive behaviour treatment, lifestyle, prevention, cardiovascular disease
InterventionThe intervention group will receive a Cognitive Behaviour Program (CBP) consisting of motivational interviewing and problem solving treatment, a program that in particular is focused on motivation and the self-management of the participants. Up to six individual CBP sessions of 30 minutes will be given, followed by three-monthly booster sessions by phone or e-mail.

Participants in the control group will receive written information and existing brochures about their risk of CVD and/or DM2.
Intervention typeOther
Primary outcome measure1. Changes in cardiovascular risk score (risk function developed by the SCORE-project)
2. Changes in diabetes risk calculation (risk function from data of the ARIC Study)
Secondary outcome measures1. Changes in lifestyle factors:
1.1. Dietary behaviour
1.2. Physical activity
1.3. Smoking behaviour
2. Changes in perceived health
3. Changes in medical care utilisation
4. Changes in waist circumference
5. Cost effectiveness and cost-utility (cost diary and Euroqol questionnaire)
Overall study start date01/08/2007
Completion date01/08/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants600
Key inclusion criteria1. Persons aged 30 to 50 years
2. With a moderate or high risk of CVD (as calculated according to the Systematic COronary Risk Evaluation [SCORE]-project)
3. Or a high risk of DM2 (as calculated according to the risk function of the Atherosclerosis Risk In Communities [ARIC] Study)
Key exclusion criteria1. Having diabetes
2. Previous CVD
3. Pregnancy
4. Current malignant disease
5. (Severe) mobility problems
Date of first enrolment01/08/2007
Date of final enrolment01/08/2010

Locations

Countries of recruitment

  • Netherlands

Study participating centre

VU University Medical Centre
Amsterdam
1081 BT
Netherlands

Sponsor information

VU University Medical Centre (VUMC) (The Netherlands)
Hospital/treatment centre

EMGO-Institute
Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands

Phone +31 (0)20 444 8180
Email emgo@vumc.nl
Website http://www.vumc.nl/english/#http://www.vumc.nl/english/
ROR logo "ROR" https://ror.org/00q6h8f30

Funders

Funder type

Research organisation

The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 04/04/2013 Yes No
Results article results 19/04/2013 Yes No